JP Morgan Chase
ZSAN

JP Morgan Chase’s Zosano Pharma Corporation ZSAN Stock Holding History

JP Morgan Chase’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-254
Closed -$14K – 6085
2020
Q3 		$14K Buy
+254
New +$11.8K ﹤0.01% 5219
2020
Q1 		– Sell
-1,750
Closed -$93K – 5884
2019
Q4 		$93K Buy
+1,750
New +$108K ﹤0.01% 4930

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's ZSAN Position: Q4 2020 in Review

JP Morgan Chase sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 254 shares — an estimated $14K sold.

JP Morgan Chase first reported a position in ZSAN in Q4 2019 and held it in 2 quarters. The position peaked at $93K in Q4 2019. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • JP Morgan Chase reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 254 Zosano Pharma Corporation shares in Q4 2020, an estimated $14K.
  • JP Morgan Chase first reported a position in Zosano Pharma Corporation in Q4 2019 and held it in 2 quarters.
  • JP Morgan Chase's Zosano Pharma Corporation position peaked at $93K in Q4 2019.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.